Oxford, UK, 17th December, 2015:
PharmaVentures is pleased to announce that it acted as advisor to Stericool on its sale to Sweden’s Getinge Group, a global leader in infection control and contamination prevention solutions.
Stericool specialises in hydrogen peroxide based solution low temperature sterilizers for emerging markets. Founded in 2008, Stericool has its headquarters and manufacturing site in Ankara, Turkey. The acquisition will be included under Getinge’s new business category unit Surgical Workflows and will increase potential for growth in East/ South Europe and the rest of the world.
Fintan Walton, Chief Executive of PharmaVentures said: "This is another important cross-border result for one of our clients. PharmaVentures continues to provide valuable advisory services across healthcare M&A and Licensing”.
Ping Shek, Vice President of PharmaVentures said: “Medical device and healthcare equipment groups remain active in M&A as adding complementary businesses to their global platforms augments organic growth”.
For over 23 years, PharmaVentures has acted as advisor to over 700 pharmaceutical and biotechnology clients in transactions; covering licensing, mergers, acquisitions, divestments and joint venture activities for companies.